The Promise of Patient-Derived Preclinical Models to Accelerate the Implementation of Personalised Medicine for Children with Neuroblastoma

Patient-derived preclinical models are now a core component of cancer research and have the ability to drastically improve the predictive power of preclinical therapeutic studies. However, their development and maintenance can be challenging, time consuming, and expensive. For neuroblastoma, a devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Tucker, Elizabeth R., George, Sally, Angelini, Paola, Bruna, Alejandra, Chesler, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065808/
https://www.ncbi.nlm.nih.gov/pubmed/33808071
http://dx.doi.org/10.3390/jpm11040248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065808/
https://www.ncbi.nlm.nih.gov/pubmed/33808071
http://dx.doi.org/10.3390/jpm11040248

Ejemplares similares